Purpose of this Study
We are doing this study to test an experimental technology that is being developed to help people monitor their symptoms and manage their care after a hospitalization for heart failure. We want to know how well the study technology, which is a virtual cardiology care application, works compared to the typical approach for helping people with heart failure manage their care after they're released back home from the hospital.
Who Can Participate?
Eligibility
Adults ages 18+ who:
- Are currently hospitalized for acute or decompensated heart failure; OR
- Were released from the hospital within the past 14 days after an inpatient stay for acute or decompensated heart failure
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Description
If you choose to join this study, you will get a random assignment (like a coin flip) to either use the study technology at home or manage your care using the typical approach.
If you are assigned to use the study technology, we will give you 4 devices to use for measuring your weight, blood pressure, oxygen level, and your heart's electrical activity. The data collected by these devices will be sent to the technology's creator, Ventricle Health, where it will be used by their clinicians to adjust your medications, if necessary.
Your participation in the study will last for about 4 months. You may be meeting virtually with a cardiologist and other health care providers that are new to you. The cardiologist may adjust your medications. The medicines used in the study will all be prescribed for heart failure and no investigational medications will be used in the study.
Locations
Remote/online
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
EVALUATION OF A VIRTUAL CARDIOLOGY PROGRAM TO IMPROVE OUTCOMES AFTER ACUTE DECOMPENSATED HEART FAILURE? THE ELEVATE-HF RANDOMIZED CONTROLLED TRIAL
Principal Investigator
Adam
Devore
Protocol Number
PRO00115672
NCT ID
NCT06592508
Phase
Pilot
Enrollment Status
Open to Enrollment